期刊文献+

以颈部淋巴结肿大和发热为首发症状的川崎病特征研究 被引量:3

Kawasaki disease with lymphadenopathy and fever as initial manifestations
原文传递
导出
摘要 目的:总结一种以颈部淋巴结肿大和发热为首发症状的川崎病的临床特点,旨在提高临床医师对该类型川崎病的认识。方法:对华中科技大学同济医学院附属协和医院2005年1月—2010年5月收治的82例川崎病患儿中的13例以颈部淋巴结肿大和发热为首发症状的川崎病患儿进行了回顾性分析。结果:该调查中共有13例以颈部淋巴结肿大和发热为首发症状的川崎病患儿,其中男9例,女4例。男女比例2.25∶1;其平均年龄5.5岁。起病至确定诊断的平均时间为8.4d。13例患儿在疾病早期全部被误诊为急性淋巴结炎而采用抗感染治疗。其中有9例(69.2%)出现冠状动脉损害。结论:以颈部淋巴结肿大和发热为首发症状的川崎病多见于年龄较大的患儿,往往表现出较强的炎症反应。而且由于其他主要临床表现在病程中出现的时间分散,容易造成川崎病诊断的延误,且其冠状动脉损害的发生率也较高。故临床上对于发热伴颈部淋巴结肿大的年长患儿,应警惕川崎病的发生,使其得到早期及时的治疗。 Objective:To describe a group of patients with kawasaki disease who had lymphadenopathy and fever as their initial manifestations.Method:We retrospectively reviewed 13 children who were admitted to wuhan Union Hospital from January,2005 to May,2010 with the initial impression of cervical lymphadenopathy and fever and which a diagnosis of kawasaki disease was established later.Result:A total of 13 patients were included in this study;9 patients male and 4 were female ;the male and female ratio is 2.25.The mean duration for establishing a diagnosis of Kawasaki disease from the onset of illness was 8.4 days.All of the 13 patients were misdiagnosed as acute cervical lymphadenitis and empiric antibiotics were prescribed in each case with unsatisfactory response.9 of the 13 patients(69.2%)developed coronary artery lesions.Conclusion:Patients with fever and lymphadenopathy as their initial presentations are older.The onset of other signs except fever and lymphadenopathy are dispersed in the course of the illness.These patients are notable for a high incidence of coronary artery involvement because of a delay in diagnosis and strong inflammation.So when children,especially older children have fever and cervical lymphadenopathy and are unresponsive to empirical antibiotics,Kawasaki disease shoule be considered so that they can be treated accurately at the early stage of illness.
出处 《临床急诊杂志》 CAS 2010年第4期237-239,共3页 Journal of Clinical Emergency
关键词 颈部淋巴结肿大 川崎病 冠状动脉损害 cervical lymphadenopathy Kawasaki disease coronary artery abnormalities
  • 相关文献

参考文献9

  • 1ROWLEY A H,GONZALEZ-CRUSSI F,SHULMAN S T.Kawasaki syndrome[J].Rev Infect Dis,1988,10:1-15.
  • 2AYUSAWA M,SONOBE T,UEMURA S,et al.Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)[J].Pediatr Int,2005,47:232-234.
  • 3胡亚美,诸福堂.实用儿科学[M].7版.北京:人民卫生出版社,2002:1174
  • 4杜忠东,张永兰,赵地,杜军保,鲁珊,衣京梅,侯安存,周忠蜀,丁国芳,林瑶,刘冲,北京小儿川崎病流行病学调查协作组.静脉丙种球蛋白无反应性川崎病的治疗及危险因素分析[J].中国实用儿科杂志,2006,21(10):738-741. 被引量:88
  • 5STAMOS J K,CORYDON K,DONALDSON J,et al.Lymphadenitis as the dominant manifestation of Kawasaki disease[J].Pediatrics,1994,93:525-528.
  • 6KAO H T,HUANG Y C,LIN T Y.Kawasaki disease presenting as cervical lymphadenitis or deep neck infection[J].Otolaryngol Head Neck Surg,2001,124:468-470.
  • 7MASARU KUBOTA,IKUYA USAMI,MASARU YAMAKAWA,et al.Early diagnosis of Kawasaki disease in patients with cervical lymphadenopathy[J].J Paediatr Child Health,2008,44:359-362.
  • 8TASHIRO N,MATSUBARA T,UCHIDA M,et al.Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease[J].Pediatrics,2002,109:E77-77.
  • 9YANAGI S,NOMURA Y,MASUDA K,et al.Early diagnosis of Kawasaki disease in patients with cervical lymphadenopathy[J].Pediatr Int,2008,50:179-183.

二级参考文献13

  • 1Du ZD,Zhang TH,Li T,et al.Epidemiologic pictures of Kawasaki disease in Beijing from 1995 through 1999[J].Pediat Infect Dis J,2002,21 (2):103-107.
  • 2Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Pediatrics,2004,114 ;1708-1733.[2]Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Pediatrics,2004,114 ;1708-1733.
  • 3Freeman AF,Shulman ST.Refractory Kawasaki disease[J].Pediatr Infect Dis J,2004,23(5):463-464.
  • 4Yanagawa H,Sonobe T.Changes in the diagnostic guidelines for Kawasaki disease.In:Yanagawa H,Nakamuru Y,Yashiro M,Kawasaki T,editors.Epidemiology of Kawasaki disease:a 30-year achievement[M].Tokyo:Shindan-To-Chiryosha,2004:24 -32.
  • 5Han RK,Silverman ED,Newman A,et al.Management and outcome of recurrent fever after intial intrarenous gammaglobulin therapy in acute Kawasaki disease[J].Arch Pediatr Adolesc Med,2000,154 (7):694-699.
  • 6Wright DA,Newburger JW,Baker A,et al.Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids[J].J Pediatr,1996,128:146-149.
  • 7Burns JC,Capparelli EV,Brown JA,et al.Intravenous gammaglobulin treatment and retreatment in Kawasakidisease.US/Canadian Kawasaki Syndrome Study Group[J].Pediatr Infect Dis J,1998,17:1144-1148.
  • 8Wallace CA,French JW,Kahn SJ,et al.Initial intravenous gammaglobulin treatment failure in Kawasaki disease[J].Pediatrics,2000,105(6):78-81.
  • 9Fukunishi M,Kikkawa M,Hamada K,et al.Prediction of non-responsiveness to intravenous high-dose γ-glubulin therapy in patients with Kawasaki disease at onset[J].J Pediatr,2000,137:172-176.
  • 10Durongpisitkul K,Soongswang J,Laohaprasitiporn D,et al.Immunoglobulin failure and retreatment in Kawasaki disease[J].Pediatr Cardiol,2003,24(2):145-148.

共引文献771

同被引文献19

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部